In a zebrafish model of mitochondrial dysfunction and age-related retinal degeneration, Telomir-Zn improved visual function, restored thickness across multiple retinal layers and lowered mitochondrial oxidative stress. The compound raised intracellular zinc while reducing labile ferrous iron, with dose-dependent increases in relative telomeric DNA content and partial normalization of methylation at aging-associated CpG loci. Findings are preclinical, and the compound is currently in an FDA-cleared Phase 1/2 program in advanced triple-negative breast cancer rather than ophthalmic disease.
Key Points
- Retinal layer thickness and visual function restored in zebrafish
- Intracellular zinc raised, labile Fe2+ and oxidative stress reduced
- Iron-dependent histone demethylases inhibited, strongest against KDM5B (63 nM)
Longevity Analysis
Trace metal balance sits upstream of epigenetic regulation: iron-dependent demethylases require ferrous iron to operate, so shifting the zinc-to-labile-iron ratio alters which genes remain accessible. That places metal handling alongside mitochondrial output as a determinant of how well post-mitotic tissue like retina sustains itself and repairs oxidative damage. The practical implication is that excess reactive iron functions as interference to be reduced rather than a deficit to be supplemented around, and that measures of labile iron and zinc status carry more interpretive weight than total serum levels.
Original published by LT Wire.